KP7 Grant for PHARMACHILD

KP7 Grant for PHARMACHILD

Dr. Nico Wulffraat, department of Child Immunology of the UMC Utrecht, receives € 3 million for the project PHARMACHILD (Long-term PHARMacovigilance for adverse effects in childhood arthritis focusing on immune modulatory drugs) in view of the KP7 program ‘Cooperation – Theme: Health’. PHARMACHILD will study the long term effects of certain medication in children with quite serious forms of childhood arthritis.

The UMC Utrecht will coordinate the establishment of a European Registry together with PRINTO, an already existing European Cooperation that coordinates the international pharmaceutical research for these children. Some laboratories (UMCU Utrecht, UMCU St Radboud, Munster, London) will at the same time study the effects on the immune system in these children.  The Erasmus MC will analyse possible reports of adverse events as malignancies or inflammatory bowel disease (IBD). Also the existing nationwide registries will be made part of the cooperation.

Source: UMC Utrecht (in Dutch)